Abstract
Decades after tuberculosis having acquired the status of curable disease, the emergence of Mycobacterium tuberculosis strains resistant to the most effective anti-tuberculosis drugs used in first-line treatment have placed this disease again as a global threat to public health. The epidemiology, pathogenesis, diagnosis and approach of drug-resistant tuberculosis in Portugal and in the world are discussed. Based on a description of a clinical case, this review highlights the difficulty and complexity of the clinical management of multi-drug resistant and extensively drugresistant tuberculosis in Portugal, a country recently considered of low incidence.
| Original language | Portuguese |
|---|---|
| Pages (from-to) | 24-34 |
| Journal | Revista Portuguesa de Doenças Infecciosas |
| Volume | 13 |
| Issue number | 1 |
| Publication status | Published - 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver